Mostly gastrointestinal nausea, vomiting, diarrhea, and constipation described as predominantly mild to moderate and dose-dependent, plus a modest heart-rate increase in the higher arms
approximately 15-30% of patients) Diarrhea (13-24%) Vomiting (6-12%) Constipation (6-17%) Abdominal pain (6-10%) Dyspepsia (6-9%) Decreased appetite (5-10%) These gastrointestinal effects are typically most pronounced during dose escalation and tend to diminish over time as the body adjusts to the medication
In addition, the healthcare provider must be knowledgeable about the potential drug interactions for each medication and dietary concern
While its known for improving physical health, some have raised concerns about how it might affect mood
Prioritize protein Include protein with every meal or snack
Monlunabant, formerly INV-202, was part of the $1B acquisition of Inversago in August 2023